Iain McGill, SVP, Europe & Rest of World at Jazz Pharmaceuticals plc (JAZZ), sold 8,000 shares at $133.42 ($1.1M) on 2017-11-17, disclosed to the SEC on 2017-11-21.
Open-market sale of $1.1M JAZZ by SVP, Europe & Rest of World. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2014-11-10 | $1.2M | — | Filing → |